105 related articles for article (PubMed ID: 17261502)
1. Induction of multilineage markers in human myeloma cells and their down-regulation by interleukin 6.
Liu S; Otsuyama K; Ma Z; Abroun S; Shamsasenjan K; Amin J; Asaoku H; Kawano MM
Int J Hematol; 2007 Jan; 85(1):49-58. PubMed ID: 17261502
[TBL] [Abstract][Full Text] [Related]
2. IL-6-induced activation of MYC is responsible for the down-regulation of CD33 expression in CD33+ myeloma cells.
Shamsasenjan K; Otsuyama KI; Abroun S; Iqbal MS; Mahmoud MS; Asaoku H; Kawano MM
Int J Hematol; 2009 Apr; 89(3):310-318. PubMed ID: 19259613
[TBL] [Abstract][Full Text] [Related]
3. Roles of protein phosphatase 1 and 2A in an IL-6-mediated autocrine growth loop of human myeloma cells.
Kang HS; Lee BS; Yang Y; Park CW; Ha HJ; Pyun KH; Choi I
Cell Immunol; 1996 Mar; 168(2):174-83. PubMed ID: 8640863
[TBL] [Abstract][Full Text] [Related]
4. Characterization of a novel interleukin-6 autocrine-dependent human plasma cell line.
Ozaki S; Wolfenbarger D; deBram-Hart M; Kanangat S; Weiss DT; Solomon A
Leukemia; 1994 Dec; 8(12):2207-13. PubMed ID: 7528862
[TBL] [Abstract][Full Text] [Related]
5. CD28, a marker associated with tumoral expansion in multiple myeloma.
Robillard N; Jego G; Pellat-Deceunynck C; Pineau D; Puthier D; Mellerin MP; Barillé S; Rapp MJ; Harousseau JL; Amiot M; Bataille R
Clin Cancer Res; 1998 Jun; 4(6):1521-6. PubMed ID: 9626472
[TBL] [Abstract][Full Text] [Related]
6. G-CSF-mobilized CD34+ cells cultured in interleukin-2 and stem cell factor generate a phenotypically novel monocyte.
Sconocchia G; Fujiwara H; Rezvani K; Keyvanfar K; El Ouriaghli F; Grube M; Melenhorst J; Hensel N; Barrett AJ
J Leukoc Biol; 2004 Dec; 76(6):1214-9. PubMed ID: 15345723
[TBL] [Abstract][Full Text] [Related]
7. [Multiple myeloma with massive ascites fluid--immunophenotypic analysis of myeloma cell and its IL-6-dependent growth].
Tatsumi T; Okada M; Yoneda Y; Maki K; Ura Y; Sawada K; Hino R; Goto H; Fujita N; Shimazaki C
Rinsho Ketsueki; 1994 Dec; 35(12):1361-5. PubMed ID: 7861616
[TBL] [Abstract][Full Text] [Related]
8. Mesenchymal stromal cells revert multiple myeloma cells to less differentiated phenotype by the combined activities of adhesive interactions and interleukin-6.
Dezorella N; Pevsner-Fischer M; Deutsch V; Kay S; Baron S; Stern R; Tavor S; Nagler A; Naparstek E; Zipori D; Katz BZ
Exp Cell Res; 2009 Jul; 315(11):1904-13. PubMed ID: 19328780
[TBL] [Abstract][Full Text] [Related]
9. CD56 expression in human myeloma cells derived from the neurogenic gene expression: possible role of the SRY-HMG box gene, SOX4.
Iqbal MS; Otsuyama K; Shamsasenjan K; Asaoku H; Kawano MM
Int J Hematol; 2010 Mar; 91(2):267-75. PubMed ID: 20049565
[TBL] [Abstract][Full Text] [Related]
10. Cooperation between heparin-binding EGF-like growth factor and interleukin-6 in promoting the growth of human myeloma cells.
Wang YD; De Vos J; Jourdan M; Couderc G; Lu ZY; Rossi JF; Klein B
Oncogene; 2002 Apr; 21(16):2584-92. PubMed ID: 11971193
[TBL] [Abstract][Full Text] [Related]
11. Disruption by interferon-alpha of an autocrine interleukin-6 growth loop in IL-6-dependent U266 myeloma cells by homologous and heterologous down-regulation of the IL-6 receptor alpha- and beta-chains.
Schwabe M; Brini AT; Bosco MC; Rubboli F; Egawa M; Zhao J; Princler GL; Kung HF
J Clin Invest; 1994 Dec; 94(6):2317-25. PubMed ID: 7989587
[TBL] [Abstract][Full Text] [Related]
12. Human bone marrow stroma-dependent myeloma sister cell lines MOLP-6 and MOLP-7 derived from a patient with multiple myeloma.
Harashima A; Matsuo Y; Nishizaki C; Kozuka T; Fukuda S; Sezaki T; Orita K
Hum Cell; 2000 Mar; 13(1):43-54. PubMed ID: 10937346
[TBL] [Abstract][Full Text] [Related]
13. The proteasome inhibitor bortezomib disrupts tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) expression and natural killer (NK) cell killing of TRAIL receptor-positive multiple myeloma cells.
Feng X; Yan J; Wang Y; Zierath JR; Nordenskjöld M; Henter JI; Fadeel B; Zheng C
Mol Immunol; 2010 Aug; 47(14):2388-96. PubMed ID: 20542572
[TBL] [Abstract][Full Text] [Related]
14. Role for interleukin-6 and insulin-like growth factor-I via PI3-K/Akt pathway in the proliferation of CD56- and CD56+ multiple myeloma cells.
Sahara N; Takeshita A; Ono T; Sugimoto Y; Kobayashi M; Shigeno K; Nakamura S; Shinjo K; Naito K; Shibata K; Otsuki T; Hayashi H; Ohnishi K
Exp Hematol; 2006 Jun; 34(6):736-44. PubMed ID: 16728278
[TBL] [Abstract][Full Text] [Related]
15. [Activation of PKA pathway inhibits reactivity of human myeloma cell line-U266 to IL-6].
Song J; Li Y; Shen B
Zhonghua Zhong Liu Za Zhi; 2001 Jul; 23(4):278-80. PubMed ID: 11783106
[TBL] [Abstract][Full Text] [Related]
16. Establishment of two interleukin 6 (B cell stimulatory factor 2/interferon beta 2)-dependent human bone marrow-derived myeloma cell lines.
Shimizu S; Yoshioka R; Hirose Y; Sugai S; Tachibana J; Konda S
J Exp Med; 1989 Jan; 169(1):339-44. PubMed ID: 2783335
[TBL] [Abstract][Full Text] [Related]
17. Analysis of IL-6-mediated growth control of myeloma cells using a gp130 chimeric receptor approach.
French JD; Tschumper RC; Jelinek DF
Leukemia; 2002 Jun; 16(6):1189-96. PubMed ID: 12040452
[TBL] [Abstract][Full Text] [Related]
18. Growth regulatory pathways in myeloma. Evidence for autocrine oncostatin M expression.
Westendorf JJ; Jelinek DF
J Immunol; 1996 Oct; 157(7):3081-8. PubMed ID: 8816418
[TBL] [Abstract][Full Text] [Related]
19. [Effect of baicalein on proliferation and migration in multiple myeloma cell lines RPMI 8226 and U266 cells].
Xu CP; Cai HL; He L; Ma Z; Liu SQ
Zhonghua Xue Ye Xue Za Zhi; 2012 Nov; 33(11):938-43. PubMed ID: 23363752
[TBL] [Abstract][Full Text] [Related]
20. CD40 expression in malignant plasma cells. Role in stimulation of autocrine IL-6 secretion by a human myeloma cell line.
Westendorf JJ; Ahmann GJ; Armitage RJ; Spriggs MK; Lust JA; Greipp PR; Katzmann JA; Jelinek DF
J Immunol; 1994 Jan; 152(1):117-28. PubMed ID: 7504707
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]